BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15059133)

  • 1. The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
    Pinheiro JP; Boos J
    Br J Haematol; 2004 Apr; 125(2):117-27. PubMed ID: 15059133
    [No Abstract]   [Full Text] [Related]  

  • 2. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
    Patil S; Coutsouvelis J; Spencer A
    Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
    Parma M; Belotti D; Pogliani EM
    Haematologica; 1996; 81(2):191. PubMed ID: 8641657
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegaspargase for acute lymphoblastic leukemia.
    Med Lett Drugs Ther; 1995 Mar; 37(944):23-4. PubMed ID: 7877556
    [No Abstract]   [Full Text] [Related]  

  • 8. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparaginase as a drug for treatment of acute lymphoblastic leukaemia.
    Gallagher MP; Marshall RD; Wilson R
    Essays Biochem; 1989; 24():1-40. PubMed ID: 2676522
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular perspective: l-asparaginase.
    Goodsell DS
    Stem Cells; 2005 May; 23(5):710-1. PubMed ID: 15849179
    [No Abstract]   [Full Text] [Related]  

  • 13. Erwinia asparaginase: coming closer to an understanding of its use in pediatric acute lymphoblastic leukemia?
    Maloney KW
    Pediatr Blood Cancer; 2010 Feb; 54(2):189-90. PubMed ID: 19967774
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase.
    Tong WH; Pieters R; van der Sluis IM
    Pediatr Blood Cancer; 2012 Feb; 58(2):317-8. PubMed ID: 22162400
    [No Abstract]   [Full Text] [Related]  

  • 15. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
    Ylikangas P; Mononen I
    Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL.
    Appel IM; Pinheiro JP; den Boer ML; Lanvers C; Reniers NC; Boos J; Pieters R
    Leukemia; 2003 Nov; 17(11):2254-6. PubMed ID: 14523472
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-linked asparaginase marketed.
    Am J Hosp Pharm; 1994 Jun; 51(11):1382. PubMed ID: 7942872
    [No Abstract]   [Full Text] [Related]  

  • 19. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.
    Rathi B; Azad RK; Vasudha N; Hissaria P; Sawlani V; Gupta RK
    Pediatr Neurosurg; 2002 Oct; 37(4):203-5. PubMed ID: 12372914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
    Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
    Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.